These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 37240007)

  • 1. Boosting the Antibacterial Activity of Azithromycin on Multidrug-Resistant
    Al-Marzooq F; Ghazawi A; Daoud L; Tariq S
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of Real-Time Assays To Distinguish Multidrug Efflux Pump-Inhibiting and Outer Membrane-Destabilizing Activities in Escherichia coli.
    Misra R; Morrison KD; Cho HJ; Khuu T
    J Bacteriol; 2015 Aug; 197(15):2479-88. PubMed ID: 25962916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Random mutagenesis of the multidrug transporter AcrB from Escherichia coli for identification of putative target residues of efflux pump inhibitors.
    Schuster S; Kohler S; Buck A; Dambacher C; König A; Bohnert JA; Kern WV
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6870-8. PubMed ID: 25182653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discerning the role of polymyxin B nonapeptide in restoring the antibacterial activity of azithromycin against antibiotic-resistant
    Al-Marzooq F; Ghazawi A; Tariq S; Daoud L; Collyns T
    Front Microbiol; 2022; 13():998671. PubMed ID: 36212888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efflux inhibitor phenylalanine-arginine beta-naphthylamide (PAβN) permeabilizes the outer membrane of gram-negative bacteria.
    Lamers RP; Cavallari JF; Burrows LL
    PLoS One; 2013; 8(3):e60666. PubMed ID: 23544160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aminoacyl β-naphthylamides as substrates and modulators of AcrB multidrug efflux pump.
    Kinana AD; Vargiu AV; May T; Nikaido H
    Proc Natl Acad Sci U S A; 2016 Feb; 113(5):1405-10. PubMed ID: 26787896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The AcrAB-TolC pump is involved in macrolide resistance but not in telithromycin efflux in Enterobacter aerogenes and Escherichia coli.
    Chollet R; Chevalier J; Bryskier A; Pagès JM
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3621-4. PubMed ID: 15328143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of outer membrane porin gene
    Luo X-W; Li P-L; Zhai Y-J; Pan Y-S; Hu G-Z; He D-D
    Microbiol Spectr; 2024 Apr; 12(4):e0391823. PubMed ID: 38441474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence, loss-of-function, or inhibition of Escherichia coli AcrB does not increase expression of other efflux pump genes supporting the discovery of AcrB inhibitors as antibiotic adjuvants.
    Ciusa ML; Marshall RL; Ricci V; Stone JW; Piddock LJV
    J Antimicrob Chemother; 2022 Feb; 77(3):633-640. PubMed ID: 34897478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic Actions of Benzyl Isothiocyanate with Ethylenediaminetetraacetic Acid and Efflux Pump Inhibitor Phenylalanine-Arginine β-Naphthylamide Against Multidrug-Resistant
    Lin KH; Lo CC; Chou MC; Yeh TH; Chen KL; Liao WY; Lo HR
    Microb Drug Resist; 2020 May; 26(5):468-474. PubMed ID: 31755808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered spectrum of multidrug resistance associated with a single point mutation in the Escherichia coli RND-type MDR efflux pump YhiV (MdtF).
    Bohnert JA; Schuster S; Fähnrich E; Trittler R; Kern WV
    J Antimicrob Chemother; 2007 Jun; 59(6):1216-22. PubMed ID: 17062614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomics Reveal Potential Natural Substrates of AcrB in Escherichia coli and Salmonella enterica Serovar Typhimurium.
    Wang-Kan X; Rodríguez-Blanco G; Southam AD; Winder CL; Dunn WB; Ivens A; Piddock LJV
    mBio; 2021 Mar; 12(2):. PubMed ID: 33785633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a novel pyranopyridine inhibitor of the AcrAB efflux pump of Escherichia coli.
    Opperman TJ; Kwasny SM; Kim HS; Nguyen ST; Houseweart C; D'Souza S; Walker GC; Peet NP; Nikaido H; Bowlin TL
    Antimicrob Agents Chemother; 2014; 58(2):722-33. PubMed ID: 24247144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total alkaloids of Sophorea alopecuroides-induced down-regulation of AcrAB-TolC efflux pump reverses susceptibility to ciprofloxacin in clinical multidrug resistant Escherichia coli isolates.
    Zhou X; Jia F; Liu X; Wang Y
    Phytother Res; 2012 Nov; 26(11):1637-43. PubMed ID: 22371352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoring colistin sensitivity in colistin-resistant
    Cui X-d; Liu X-k; Ma X-y; Li S-h; Zhang J-k; Han R-j; Yi K-f; Liu J-h; Pan Y-s; He D-d; Hu G-z; Zhai Y-j
    mSphere; 2024 Jun; 9(6):e0018224. PubMed ID: 38738873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An efflux pump (MexAB-OprM) of Pseudomonas aeruginosa is associated with antibacterial activity of Epigallocatechin-3-gallate (EGCG).
    Kanagaratnam R; Sheikh R; Alharbi F; Kwon DH
    Phytomedicine; 2017 Dec; 36():194-200. PubMed ID: 29157815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic analysis of the inhibition of the drug efflux protein AcrB using surface plasmon resonance.
    Mowla R; Wang Y; Ma S; Venter H
    Biochim Biophys Acta Biomembr; 2018 Apr; 1860(4):878-886. PubMed ID: 28890187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of Efflux Pump Inhibitors on the Activity of Selected Non-Antibiotic Medicinal Products against Gram-Negative Bacteria.
    Laudy AE; Kulińska E; Tyski S
    Molecules; 2017 Jan; 22(1):. PubMed ID: 28085074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phenylalanine-arginine beta-naphthylamide sensitive multidrug efflux pump involved in intrinsic and acquired resistance of Campylobacter to macrolides.
    Mamelli L; Amoros JP; Pagès JM; Bolla JM
    Int J Antimicrob Agents; 2003 Sep; 22(3):237-41. PubMed ID: 13678827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efflux pump inhibitor phenylalanine-arginine β-naphthylamide (PAβN) increases resistance to carbapenems in Chilean clinical isolates of KPC-producing Klebsiella pneumoniae.
    Vera-Leiva A; Carrasco-Anabalón S; Lima CA; Villagra N; Domínguez M; Bello-Toledo H; González-Rocha G
    J Glob Antimicrob Resist; 2018 Mar; 12():73-76. PubMed ID: 29275225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.